Brain injuries
Breakthrough in Brain Injury Research: Perampanel Shows Significant Advantage in Preventing Acute Symptomatic Seizures
Researchers from Osaka Medical and Pharmaceutical University have published a study in Frontiers in Neurology comparing the effectiveness of perampanel and levetiracetam in preventing acute symptomatic seizures (ASS) following moderate to severe traumatic brain injury (TBI). The study found that perampanel demonstrated a significant advantage over levetiracetam in preventing ASS,